The Effects of Obesity on Lymphatic Pain and Swelling in Breast Cancer Patients

Mei R. Fu, Deborah Axelrod, Amber Guth, Melissa McTernan, Jeanna M. Qiu, Zhuzhu Zhou, Eunjung Ko, Cherlie Magny‐Normilus, Joan Scagliola, Yao WangBiomedicines 2021 · DOI

TL;DR

This study investigated the impact of obesity on patient-reported lymphatic pain and swelling in breast cancer survivors. It found that obesity (defined as BMI ≥ 30 kg/m²) significantly increases the odds of experiencing lymphatic pain and arm swelling, even after accounting for other clinical and demographic factors. This highlights obesity as a modifiable risk factor for these debilitating post-treatment symptoms.

What Problem Does This Paper Address?

Breast cancer treatment, while increasingly successful in improving survival rates, often leaves survivors with long-term, debilitating side effects. Among the most common and impactful are lymphatic pain and swelling, collectively referred to as lymphedema. These symptoms arise from impaired lymphatic fluid drainage and can significantly reduce a patient's quality of life. While obesity has been previously linked to increased risk of breast cancer and objective measures of arm swelling (like increased limb size), its specific impact on patient-reported symptoms like pain and swelling, and particularly truncal swelling, remained less clear. This paper aims to quantify the association between obesity and these patient-centered outcomes, controlling for other known risk factors.

Methods

The researchers employed a cross-sectional, observational study design. They recruited 554 breast cancer survivors who had completed acute treatment. Key measurements included:

  • Body Composition: A bioimpedance analysis (BIA) device was used to measure Body Mass Index (BMI), body fat percentage, and body fat mass. Obesity was defined using the standard criterion of BMI ≥ 30 kg/m².
  • Symptom Assessment: The Breast Cancer and Lymphedema Symptom Experience Index (BCLE-SEI) Part I, a validated self-report instrument, was used to assess the occurrence and severity of lymphatic pain, arm swelling, and truncal swelling over the preceding three months.
  • Clinical and Demographic Data: Information on age, ethnicity, marital status, education, financial status, employment, type of surgery, lymph node procedures, radiotherapy, chemotherapy, hormonal therapy, diabetes, and lymphedema diagnosis was collected.

Statistical analysis involved descriptive statistics, t-tests and chi-square tests for group comparisons, and crucially, multivariable logistic regression models. These models were used to estimate Odds Ratios (OR) with 95% Confidence Intervals (CI) to quantify the effect of obesity on each symptom, while controlling for a comprehensive set of clinical and demographic covariates, as well as body fat percentage.

Datasets

The study utilized data collected from 554 breast cancer patients at NYU Perlmutter Cancer Center. This dataset is a newly collected cohort for this specific research question. No external datasets were used for training or evaluation.

Key Insights and Ideas

  • Obesity as a Major Driver of Patient-Reported Symptoms: The study strongly suggests that obesity is not just a risk factor for objective lymphedema, but a significant contributor to the experience of lymphatic pain and arm swelling. This is crucial because patient perception of symptoms directly impacts their quality of life.
  • Distinguishing Symptom Types: While obesity strongly influenced lymphatic pain and arm swelling, its effect on truncal swelling was not statistically significant after controlling for other factors. This hints at potentially different underlying mechanisms or contributing factors for truncal swelling compared to arm symptoms.
  • Modifiable vs. Non-Modifiable Risk Factors: The research highlights obesity as a key modifiable risk factor for these symptoms, contrasting with non-modifiable factors like radiotherapy or mastectomy. This underscores the potential for lifestyle interventions to improve patient outcomes.
  • Interplay of Socioeconomic Factors: The finding that financial hardship is also associated with increased odds of lymphatic pain and arm swelling, and that obesity is more prevalent in certain demographic groups, points to the complex interplay of socioeconomic status, race, and health outcomes.

Key Results

  • Lymphatic Pain: Patients with obesity (BMI ≥ 30 kg/m²) had significantly higher odds of experiencing lymphatic pain (OR = 3.49, 95% CI 1.87–6.50; p < 0.001) compared to non-obese patients, even after controlling for other factors.
  • Arm Swelling: Obesity was also a significant predictor of arm swelling (OR = 3.98, 95% CI 1.82–4.43; p < 0.001), showing the strongest association among the symptoms studied.
  • Truncal Swelling: Obesity did not show a statistically significant effect on truncal swelling after controlling for covariates (OR = 1.85, 95% CI 1.00–3.42; p = 0.051, but not reaching significance in the multivariable model).
  • Body Fat vs. BMI: Interestingly, even after controlling for body fat percentage, obesity (defined by BMI) remained a significant predictor for lymphatic pain and arm swelling, suggesting BMI is a robust indicator in this context.

Limitations and Future Work

The authors acknowledge several limitations:

  • Cross-sectional Design: This design prevents establishing causality or observing changes over time. It can only show associations.
  • Self-Reported Data: While validated instruments were used, reliance on self-report can be subject to recall bias or subjective interpretation.
  • Specific Population: The study was conducted at a single cancer center, which might limit generalizability.

Future work suggested by the authors includes:

  • Longitudinal Studies: To better understand the temporal relationship between obesity, symptom development, and progression.
  • Exploring Inflammatory Pathways: Given that obesity, pain, and swelling are inflammatory conditions, future research should delve into the molecular mechanisms to identify potential therapeutic targets.
  • Comparing Measurement Methods: Investigating the predictive sensitivity of BMI versus body fat percentage and body fat mass for patient-centered outcomes.
  • Holistic Approach: Developing interventions that address obesity management, lifestyle changes, and potentially socioeconomic support to reduce the burden of these symptoms.

Summary updated

Abstract

Lymphatic pain and swelling due to lymph fluid accumulation are the most common and debilitating long-term adverse effects of cancer treatment. This study aimed to quantify the effects of obesity on lymphatic pain, arm, and truncal swelling. <b>Methods:</b> A sample of 554 breast cancer patients were enrolled in the study. Body mass index (BMI), body fat percentage, and body fat mass were measured using a bioimpedance device. Obesity was defined as a BMI ≥ 30 kg/m<sup>2</sup>. <i>The Breast Cancer and Lymphedema Symptom Experience Index</i> was used to measure lymphatic pain, arm, and truncal swelling. Multivariable logistic regression models were used to estimate the odds ratio (OR) with 95% confidence interval (CI) to quantify the effects of obesity. <b>Results:</b> Controlling for clinical and demographic characteristics as well as body fat percentage, obesity had the greatest effects on lymphatic pain (OR 3.49, 95% CI 1.87-6.50; <i>p</i> < 0.001) and arm swelling (OR 3.98, 95% CI 1.82-4.43; <i>p</i> < 0.001). <b>Conclusions:</b> Obesity is a significant risk factor for lymphatic pain and arm swelling in breast cancer patients. Obesity, lymphatic pain, and swelling are inflammatory conditions. Future study should explore the inflammatory pathways and understand the molecular mechanisms to find a cure.
BibTeX
@inproceedings{fu2021effects,
  author = {Mei R. Fu and Deborah Axelrod and Amber Guth and Melissa McTernan and Jeanna M. Qiu and Zhuzhu Zhou and Eunjung Ko and Cherlie Magny‐Normilus and Joan Scagliola and Yao Wang},
  title = {{The Effects of Obesity on Lymphatic Pain and Swelling in Breast Cancer Patients}},
  booktitle = {Biomedicines},
  year = {2021},
  doi = {10.3390/biomedicines9070818},
}
Figure